There is no standardized conclusion on how long the dermal implantation treatment for epilepsy works, and at the same time, clinical practice does not recommend treating epilepsy by means of dermal implantation treatment for epilepsy medicine. Patients are advised to take oral antiepileptic drugs (e.g. carbamazepine, sodium valproate, etc.) under the supervision of a physician to control the condition. The skin is usually cut open and the antiepileptic drugs are buried under the skin and released slowly to achieve the antiepileptic effect. However, there is no standardization on the duration of slow release and there is a lack of clinical evidence on the use of subcutaneous epileptic drugs, so the use of subcutaneous epileptic drugs is not clinically supported for the time being. It is recommended that patients with epilepsy use antiepileptic drugs, such as carbamazepine, valproate, lamotrigine, etc., under the guidance of a doctor, and do not use the so-called skin-embedded therapy on their own to avoid aggravation of the condition.